From Days to Hours: MicroGenDX Ushers in Next-Day NGS Results
ORLANDO, FLORIDA / ACCESS Newswire / July 7, 2025 / MicroGenDX, a national leader in molecular diagnostics, announces the integration of the Illumina MiSeq i100 Plus platform into its lab operations. This advanced DNA sequencing platform enables MicroGenDX to be the only NGS testing provider that delivers test results within 24 hours after sample receipt, empowering providers, hospitals, and patients with faster answers that unlock better care.
MicroGenDX combines Next-Gen DNA Sequencing (NGS) with PCR to identify over 57,000 bacterial and fungal pathogens and 17 types of antibiotic resistance-helping providers make well-informed, clinically relevant decisions.
Improving Infectious Disease Diagnostics
Compared to MicroGenDX’s original platform, the MiSeq i100 Plus delivers an 80% faster run time, with high-output runs completed in just 12 hours. This enables next-day reporting and greater batch efficiency for high-throughput hospital needs.
Combined with a simplified report format that combines the results of both qPCR and NGS tests, the platform upgrade drastically reduces diagnostic delays caused by lags in reporting, especially for critically ill or rapidly declining patients.
For hospital and clinical partners (especially high-volume ones), this contributes to faster diagnostic insights, more efficient results reporting, and a better path to precision diagnosis. For patients, this means better answers in less time, allowing them to overcome infection quicker than ever.
Clinical and Operational Advantages
Processing multiple NGS batches daily, MicroGenDX increases throughput, expanding access to molecular testing and faster turnarounds for providers.
Rick Martin, CEO of MicroGenDX said:
“This platform is more than a performance upgrade, it’s a shift toward faster, smarter, scalable sequencing. We’re excited about the possibilities this opens for our partners and the patients they serve.”
In addition, the new platform creates other benefits for MicroGenDX’s clinical operations such as improving reliability of NGS detection and producing richer sequencing data. It also reduces carbon impact by 35% and packaging waste by 85%.
Ready for Day One Usage
MicroGenDX will continue to accept the same wide range of multi-specialty sample types and process them on the new platform. These include:
Blood
BAL and sputum
CSF
Pleural, peritoneal, and synovial fluids
Urine
Semen
Vaginal and sinus swabs
Wound tissue and bone
Other sterile site samples
Built Ready for the Future
The MiSeq i100 Plus enhances MicroGenDX’s ability to respond to infectious disease outbreaks, support antimicrobial stewardship efforts, and uphold regulatory compliance with high-quality data.
This development reinforces MicroGenDX’s commitment to delivering cutting-edge sequencing services to create clinical clarity in all healthcare environments.
About MicroGenDX
MicroGenDX is a national leader in NGS testing for microbial identification. Its CLIA, CAP, and CLEP-certified lab serves clinicians across urology, orthopedics, infectious disease, women’s health, and more. Learn more at microgendx.com or patients.microgendx.com
RICHARDSON, TX / ACCESS Newswire / July 7, 2025 / Optex Systems Holdings, Inc. (NASDAQ:OPXS), a leading manufacturer of precision optical sighting systems for domestic and worldwide military and commercial applications, announced today it has been awarded a $2.8 million purchase order from a major U.S. prime contractor in support of the XM30 Combat Vehicle. This contract will provide 13 sighting systems in support of the next milestone with deliveries in fiscal 2026.
Danny Schoening, CEO, stated “We are pleased to have been chosen for this critical optical assembly which encompasses many of Optex’s core competencies. The customer’s requirements, including a limited space claim, dictated an extremely complex optical design. By utilizing optical building blocks from previous designs combined with emerging technology, Optex will provide an elegant, robust, and serviceable solution.”
The periscopes and optical sighting systems supplied by Optex Systems are designed to offer enhanced durability, superior optical clarity, and exceptional reliability in harsh combat environments. By combining innovation with rigorous quality control measures, the company ensures that every system delivers the best overall value to the U.S. Army.
As a trusted partner of the defense industry, Optex Systems remains dedicated to advancing military optical technologies that enhance situational awareness and protection on the battlefield. This contract award reaffirms the company’s leadership in the field of laser-protected vision systems and its ongoing commitment to supporting the mission readiness of U.S. forces and those of our allies.
With this order, the current Optex backlog is in excess of $41.4 million.
ABOUT OPTEX SYSTEMS
Optex, which was founded in 1987, is a Richardson, Texas based ISO 9001:2015 certified concern, which manufactures optical sighting systems and assemblies, primarily for Department of Defense (DOD) applications. Its products are installed on various types of U.S. military land vehicles, such as the Abrams and Bradley fighting vehicles, Light Armored and Armored Security Vehicles, and have been selected for installation on the Stryker family of vehicles. Optex also manufactures and delivers numerous periscope configurations, rifle and surveillance sights, and night vision optical assemblies. Optex delivers its products both directly to the military services and to prime contractors. For additional information, please visit the Company’s website at www.optexsys.com.
Safe Harbor Statement
This press release contains certain forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995, including those relating to the products and services described herein. You can identify these statements by the use of the words “may,” “will,” “could,” “should,” “would,” “plans,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” “likely,” “forecast,” “probable,” and similar expressions. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. Such risks and uncertainties include, but are not limited to, continued funding of defense programs and military spending, the timing of such funding, general economic and business conditions, including unforeseen weakness in the Company’s markets, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, changes in the U.S. Government’s interpretation of federal procurement rules and regulations, changes in spending due to policy changes in any new federal presidential administration, market acceptance of the Company’s products, shortages in components, production delays due to performance quality issues with outsourced components, inability to fully realize the expected benefits from acquisitions and restructurings or delays in realizing such benefits, challenges in integrating acquired businesses and achieving anticipated synergies, changes to export regulations, increases in tax rates, changes to generally accepted accounting principles, difficulties in retaining key employees and customers, unanticipated costs under fixed-price service and system integration engagements, changes in the market for microcap stocks regardless of growth and value and various other factors beyond our control.
You must carefully consider any such statement and should understand that many factors could cause actual results to differ from the Company’s forward-looking statements. These factors include inaccurate assumptions and a broad variety of other risks and uncertainties, including some that are known and some that are not. No forward-looking statement can be guaranteed and actual future results may vary materially. The Company does not assume the obligation to update any forward-looking statement. You should carefully evaluate such statements in light of factors described in the Company’s filings with the SEC, especially on Forms 10-K, 10-Q and 8-K. In various filings the Company has identified important factors that could cause actual results to differ from expected or historic results. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete list of all potential risks or uncertainties.
West Coast Tire and Services is rolling out a new initiative focused on boosting customer engagement and improving service delivery in South Orange County, California. Their goal is to provide reliable auto services, meeting the increasing demand for dependable vehicle care. This announcement highlights their continued dedication to quality, particularly in offering comprehensive solutions for vehicle maintenance in the area.
Over the years, West Coast Tire and Services has earned a solid reputation for quality. Their recent initiative highlights their specialized services, including Auto Repair San Juan Capistrano, which effectively addresses common vehicle issues. The team aims to keep vehicles running at their best and emphasizes factory-scheduled maintenance as a critical service that helps ensure vehicles last longer and perform well.
Todd, from West Coast Tire and Services, offers insight into the company’s goals: “Our mission is to provide exceptional service that not just meets but exceeds expectations. By focusing on Auto Repair San Juan Capistrano and highlighting the importance of regular maintenance, we aim to educate customers on the benefits of keeping their vehicles in optimal running condition.”
Regular factory scheduled maintenance is key to keeping vehicles in line with manufacturer recommendations. This not only boosts performance but also enhances safety. West Coast Tire and Services understands that these scheduled check-ups can help prevent costly repairs and unexpected breakdowns. It’s part of their proactive strategy to provide dependable service that tackles core maintenance issues.
Beyond mechanical repairs, this initiative includes a wide range of services designed to offer complete care for all types of vehicles. With thorough inspections, detailed diagnostics, and clear communication about the condition of vehicles, customers can expect to make well-informed decisions when it comes to repairs or necessary maintenance tasks.
Customer satisfaction has always been a priority for West Coast Tire and Services. They focus on building trust and fostering long-term relationships by being transparent and meticulous in their auto-care approach. By educating customers about important topics, such as factory-scheduled maintenance, they encourage routine check-ups, which can help prevent future problems.
Todd remarks, “Customer education is key. We strive to inform them about the benefits of regular maintenance and how it helps avoid bigger issues in the future. Our team is committed to providing clear, honest advice to aid in sound decision-making regarding vehicle care.”
For those in the area seeking thorough automotive services, West Coast Tire and Services stands out as a reliable choice. They understand the distinct needs of the community and have adapted their services to meet these effectively. Discover the wide range of services they offer, including auto repair, diesel repair, and maintenance services, by visiting their website. Their focus on a customer-first approach underscores their commitment to making sure every vehicle is in the best possible condition when it leaves their care.
West Coast Tire and Services continues to play an important role in the automotive industry in South OC, promoting safer roads through responsible car maintenance practices. Their strategies demonstrate how they adapt to meet the evolving needs of their clients, consistently prioritizing quality and reliability.
West Coast Tire and Services consistently provides essential auto care, following industry standards and integrating Auto Repair in and around San Juan Capistrano with a focus on factory scheduled maintenance into their service offerings. Their constant commitment to customer care and vehicle performance is evident in their strategic initiatives, which aim to improve community well-being through attentive and proactive auto servicing.
This initiative sets a new benchmark in vehicle maintenance services, strengthening West Coast Tire and Services’ position as a trusted provider in the South Orange County community. They look forward to continuing these efforts in collaboration with their valued customers. For further details, visit their website or call 949-493-7733.
West Coast Tire & Services, a well-known auto care provider located in San Juan Capistrano, California, is expanding its service area to include San Clemente. This move aims to provide high-quality, dependable automotive services to more people in South Orange County. Since 2006, the company has been offering trusted auto services, and now they want more residents to benefit from their expertise. As a certified GoodYear Auto Service Center Tire Dealer, West Coast Tire & Services is dedicated to upholding its high standards and excellent customer service reputation. Customers can learn more about their wide range of services on the company’s official website, West Coast Tire & Services is a full-service auto repair and maintenance shop based in San Juan Capistrano, California.
Now serving San Clemente, West Coast Tire & Services will provide the same wide range of maintenance and repair services that have built their strong reputation. These services include general auto repair, diesel vehicle services, engine rebuilding, radiator repair, brake repair and much more. The team consists of ASE-certified technicians who use the latest automotive technology to deliver top-notch results for both foreign and domestic vehicles.
“We are thrilled to extend our services to the residents of San Clemente,” said Todd, a representative from West Coast Tire & Services. “Our goal is to provide the same high level of service and customer satisfaction that our existing customers have come to expect. By bringing our services closer to them, we hope to make high-quality auto care more accessible and convenient for the community.”
This expansion reflects West Coast Tire & Services’ promise to offer honest and professional automotive repair and maintenance services at competitive prices. With advanced diagnostic equipment and financing options available through our website, the company aims to offer cost-effective solutions without cutting corners on quality. In addition to its general services, customers can access specialized options such as brake repair, fuel injector cleaning, and suspension repairs, making it a one-stop shop for all their auto care needs.
The decision to offer auto repair to San Clemente area stems from a need for reliable and reasonably priced automotive services in South Orange County. More details about their offerings, including the fact they are a certified Goodyear Service Center, can be found at their online presence. West Coast Tire & Services is known for not charging the high rates often seen at car dealerships. They aim to fill this gap by bringing their tradition of quality to a new audience. Customers in San Clemente will now experience the same exceptional tire repair, engine servicing, and vehicle maintenance that have distinguished the company’s offerings for years.
Expanding into San Clemente also aims to make things more convenient for customers. By providing a local option for professional automotive care, West Coast Tire & Services looks to establish a strong community presence and build long-lasting relationships with new clients. These efforts are part of the company’s ongoing mission to deliver automotive service that meets the highest industry standards, backed by years of expertise and a commitment to customer satisfaction.
“We see this expansion as a natural progression of our mission to offer excellent automotive services to more people in our region. We’re excited about the opportunity to serve San Clemente and look forward to becoming a trusted part of this community,” Todd added.
Residents of San Clemente can expect West Coast Tire & Services to maintain the values and service quality that have made their San Juan Capistrano shop thrive. By combining advanced technology with skilled craftsmanship, they are set to be a key player in ensuring safe and reliable transportation for San Clemente’s residents. More information about their ASE-certified technicians and service capabilities is readily accessible online, offering customers easy access to full details on what they can expect in terms of service excellence.
This strategic expansion into San Clemente marks an important milestone for West Coast Tire & Services. It enables the company to expand its high-quality automotive services to new customers, underscoring its commitment to providing affordable and reliable car care throughout South Orange County. This new development is expected to benefit the community by enhancing the availability of superior auto repair services locally. Further insights into their services, including detailed information about engine rebuilding and radiator repair, are available on their official website.
Spine Surgeon Returns to Competitive Sports, Completes a Triathlon Just 8 Months After Successful Motion-Preserving Spine Surgery
PALM BEACH, FL / ACCESS Newswire / July 7, 2025 / When Dr. Scott Adelman, a nationally recognized leader in endoscopic spine surgery and interventional pain management, began experiencing debilitating low back pain, he understood better than most the complexities and limitations of traditional surgical options. For years, he pursued conservative treatments-physical therapy, spinal injections, and careful lifestyle modifications-but the pain continued to escalate, eventually preventing him from enjoying the activities that once defined his active lifestyle. Competitive snow skiing, triathlons, and fly fishing in the mountains near his Park City, Utah home had all become nearly impossible.
At 62, with his quality of life rapidly declining, Dr. Adelman consulted with several spine specialists. The consensus was a lumbar fusion-a common solution, but one that would restrict mobility and potentially curtail his ability to remain active. For a surgeon who had built his career advocating for minimally invasive, motion-preserving solutions, this was not acceptable.
Determined to explore every option, Dr. Adelman turned to Dr. Jason M. Cuéllar, a fellowship-trained orthopedic spine surgeon known for his expertise in advanced motion-preserving spinal procedures. Practicing in Palm Beach, Jupiter and Miami, Florida, Dr. Cuéllar has become a leader in artificial disc replacement and innovative alternatives to fusion.
Together, Dr. Adelman and Dr. Cuéllar developed a tailored treatment plan focused on preserving motion and function. For Dr. Adelman, the goal was not just pain relief, but the restoration of a life filled with movement, performance, and passion. In October 2024, Dr. Cuéllar performed a three-level lumbar artificial disc replacement (ADR) using the ProDisc system. The procedure involved disc arthroplasty at the L3-4, L4-5, and L5-S1 levels. Conducted through a standard anterior retroperitoneal approach, Dr. Cuéllar was able to completely remove the damaged discs and precisely implant the artificial discs at all three levels, preserving Dr. Adelman’s spinal motion and improving his quality of life.
“Scott’s case was complex, but he was an excellent candidate for lumbar disc replacement,” said Dr. Cuéllar. “Given his active lifestyle, preserved facet joints, and desire to avoid fusion, multilevel ADR offered the best opportunity to relieve his pain while preserving motion across the lumbar spine. I am thrilled with his recovery and his return to high-level activities-including a triathlon at 8 months post-op!”
Dr. Adelman’s surgical outcome has been exceptional. By four months postoperatively, he was back on the slopes skiing black diamond runs in Park City. Eight months after surgery, Adelman completed a triathlon with no back pain. “It was discouraging to think that most of my lumbar spine would be fused,” said Dr. Adelman. “Recovery would have taken at least six months, and I would have lost mobility at those levels. Dr. Cuéllar’s expertise in multilevel total disc replacement prevented me from that outcome. I am not only grateful for the surgical result but for the ability to resume the activities I love.”
Dr. Adelman’s career as a pioneer in endoscopic spine surgery has been unique. Without following the traditional U.S. spine surgery training pathway, he built an international reputation through more than two decades of performing endoscopic spinal decompressions, helping thousands of patients avoid open surgery. His nontraditional background and innovative approach to spinal care made him an early advocate for minimally invasive techniques that prioritize motion preservation-values that aligned closely with Dr. Cuéllar’s expertise in artificial disc replacement.
Dr. Cuéllar, founder at Cuéllar Spine and a member of the national ADR Spine Top Doctors in Arthroplasty Program, continues to build a reputation for successfully treating complex lumbar and cervical disc disease with motion-preserving surgical solutions. His growing referral base includes not only patients but also physicians and spine care specialists seeking second opinions and alternatives to spinal fusion.
For Dr. Adelman, the choice to pursue total disc replacement reflects both professional insight and personal experience. His story underscores the expanding role of lumbar TDR as a preferred option for appropriately selected patients with multi-level degenerative disc disease.
About Dr. Jason M. Cuéllar
Jason M. Cuéllar, M.D., Ph.D., is a fellowship-trained orthopedic spine surgeon with a practice focused exclusively on motion preservation and minimally invasive spine surgery. Based in Palm Beach, Jupiter and Miami, Florida, Dr. Cuéllar is a recognized leader in total disc replacement (TDR) for both the cervical and lumbar spine. As one of the earliest inductees into the ADR Spine Top Doctors in Arthroplasty Program, he is frequently sought out by patients nationwide seeking alternatives to spinal fusion. Dr. Cuéllar’s academic contributions include over three dozen peer-reviewed publications in the field of spine surgery, and he continues to participate in clinical research advancing the science of motion preservation. For more information, visit www.CuellarSpine.com.
About Dr. Scott Adelman
Dr. Scott Adelman is a board-certified physiatrist and a national leader in interventional spine care and endoscopic spine surgery. Based in Park City, Utah, Dr. Adelman has spent over two decades pioneering minimally invasive techniques that help patients avoid traditional open spine surgeries. With a background in physical medicine and rehabilitation, he has developed specialized expertise in outpatient endoscopic procedures, treating thousands of patients with chronic back and neck pain. Dr. Adelman continues to lecture nationally and internationally on advanced spine care techniques, with a professional focus on helping patients preserve spinal function and avoid unnecessary fusion surgeries. For more information, visit www.thesmartclinic.com.
About the ADR Spine Top Doctors in Arthroplasty Program
The ADR Spine Top Doctors in Arthroplasty Program recognizes and supports the nation’s leading surgeons in motion preservation spine surgery. Founded by Dr. Todd H. Lanman, the program highlights physicians who meet rigorous standards for clinical excellence, surgical volume, and patient outcomes in total disc replacement (TDR) and other motion-preserving procedures. Program members are selected for their commitment to innovation, patient-centered care, and their expertise in restoring spinal motion for individuals suffering from degenerative spine conditions. For more information, visit www.adrspine.com.
Venture Medical, LLC, a leader in advanced wound care solutions, today announced the closing of a strategic investment in Plasmacure B.V
MISSOULA, MT / ACCESS Newswire / July 7, 2025 / Venture Medical, LLC, a leader in advanced wound care solutions, today announced the closing of a strategic investment in Plasmacure B.V., the Dutch MedTech innovator behind PLASOMA, an award-winning cold plasma therapy for complex wound healing. Venture Medical is leading a €6 million Series A round alongside Coöperatie VGZ, Noaber, Stichting Triade, and existing investors EIC Fund and OostNL. In addition to the direct investment, Venture Medical is also committing over $10 million to support PLASOMA’s regulatory approval, reimbursement efforts, and U.S. market expansion.
Cold Plasma Wound Healing Technology from Plasmacure Showing How Cold Plasma Wound Healing Technology from Plasmacure Works on a Patient
This partnership underscores Venture Medical’s ongoing mission to empower providers to deliver healing without boundaries by introducing disruptive technologies that improve patient outcomes and expand access to state-of-the-art care.
“As a leading cause of amputations, sepsis, and many other severe complications, chronic wounds impact the lives of millions of patients while presenting a growing burden to our healthcare system,” said John Schroeder, CEO of Venture Medical. “We see PLASOMA as a transformative technology that redefines what’s possible in wound healing. By investing in Plasmacure and supporting its U.S. rollout, we are enabling clinicians to offer next-generation care that is both innovative and accessible.”
PLASOMA is a novel wound healing system delivering cold plasma through an intuitively designed pulser and specialized applicator, safely generating plasma from room air directly on the wound surface. Cold plasma has demonstrated powerful antimicrobial effects, while simultaneously promoting tissue regeneration through a variety of other mechanisms. In a recent clinical trial, PLASOMA therapy showed 2.5 times more wound closure than current standards of care.
For Venture Medical, the investment is part of a broader commitment to helping healthcare providers access groundbreaking tools across biologics, diagnostics, durable medical equipment, and digital solutions. PLASOMA aligns directly with this vision by offering a scalable, scientifically backed option for treating diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other hard-to-heal wounds.
“As our population ages and chronic conditions become more prevalent, the need for effective wound healing solutions grows more urgent,” added Schroeder. “With PLASOMA, we’re not just treating wounds, we’re restoring access, independence, and dignity to patients who’ve been living without hope.”
The funding will accelerate Plasmacure’s global scale-up while laying the groundwork for U.S. FDA clearance, payer access, and national distribution through Venture Medical’s extensive provider network.
“We are deeply motivated by the needs of the millions living with hard-to-heal wounds,” said Bjorn Sprengers, CEO of Plasmacure. “With this investment and our new strategic partners, we are in a strong position to bring PLASOMA to more patients worldwide.”
About Venture Medical, LLC Venture Medical is a U.S.-based healthcare services company specializing in advanced wound care. As a master distributor and digital solutions partner, Venture Medical equips clinicians with breakthrough biologics, diagnostics, and capital equipment to improve patient outcomes across care settings. Learn more at www.venturemedical1.com.
About Plasmacure B.V. Founded in 2014 in the Netherlands, Plasmacure is the developer of PLASOMA, a cold plasma therapy designed to accelerate healing in chronic wounds. The company aims to revolutionize wound care through safe, effective, and scalable technology. Visit www.plasmacure.nl to learn more.
REDMOND, WA / ACCESS Newswire / July 7, 2025 / CoreStack, the global leader in AI-powered next-generation cloud governance, today announced the launch of CoreStack Graphion™, a breakthrough Cloud-Native Application Protection Platform (CNAPP) engineered for today’s hyper-connected, high-velocity software ecosystems. With the escalating threat landscape and mounting compliance mandates, Graphion redefines security by fusing Agentic AI, deep SBOM + IBOM intelligence, and real-time graph-based threat modeling into a single, unified platform.
“Security can’t wait – and with Graphion, it doesn’t have to,” said Ezhilarasan Natarajan, Chief Executive Officer at CoreStack. “We’ve fused intelligence and action to give security leaders what they really need: clarity, prioritization, and control. Graphion doesn’t just show what’s vulnerable – it shows what matters.”
This innovation is further accelerated by CoreStack’s recent acquisition of Karthik Consulting (KC), a federal cybersecurity and DevSecOps leader. By combining KC’s deep expertise in secure federal systems, with CoreStack’s AI-powered governance platform, the two companies are unifying their strengths to deliver an integrated CNAPP offering. This strategic alignment amplifies CoreStack’s platform capabilities with federal-grade security, ensuring both enterprise and government customers benefit from a secure, scalable, and compliance-ready solution.
Built for the New Reality of Cloud Risk
Today’s cloud-native applications are assembled rapidly from a vast and volatile software supply chain, then deployed into ephemeral, containerized infrastructure. This agility introduces new risks at every turn – from unscanned code to misconfigured assets and overlooked policy drift.
Graphion addresses these risks head-on, offering:
A living graph of application, infrastructure, security posture and its attack path.
Unified visibility through integrated SBOM (Software Bill of Materials) and IBOM (Infrastructure Bill of Materials).
Intelligent prioritization based on business impact and real-world exploitability.
Agentic AI That Understands Context and Drives Action
At the core of Graphion is CoreStack’s Large Cloud Governance Model™ (LCGM) – an Agentic AI engine that goes beyond classification to deliver targeted, autonomous responses. It continuously:
Understands application context and business criticality.
Flags vulnerabilities based on real-world risk propagation.
Recommends and explains precise remediation paths.
Designed for Real Security, Not Just Policy
Graphion brings together visibility, enforcement, and validation to deliver on the promise of Zero Trust. It:
Validates every change, deployment, and connection against policy.
Automates continuous ATO (cATO) with built-in compliance artifacts.
Tracks posture across time and environments for true auditability.
By embedding controls directly into the DevSecOps pipeline, Graphion replaces fragmented reviews with continuous, automated assurance.
Built for the Enterprise. Ready for the Mission.
Graphion integrates seamlessly with leading cloud platforms (Azure, AWS, GCP, Oracle) and supports critical frameworks such as NIST, FedRAMP, and EO 14028. With modular deployment, out-of-the-box integrations, and a graph data model built for extensibility, it empowers enterprises to govern their software supply chain – securely, autonomously, and at scale.
Join the Preview
Select enterprise and federal partners are now onboarding to the Graphion early access program, gaining firsthand access to its powerful graph-based security engine and AI-driven insights.
BEIJING, CHINA AND MADRID, SPAIN / ACCESS Newswire / July 7, 2025 / Hygreen Energy , a global electrolyzer manufacturer and hydrogen technology leader, has entered a frame agreement with Robert Bosch GmbH to integrate Bosch’s Hybrion PEM electrolysis stacks into Hygreen’s large-scale PEM hydrogen system offerings. Through this multi-year partnership, Hygreen will bring a fully commercially ready, large-scale hydrogen production system to worldwide markets using Bosch Hybrion PEM stacks.
As a result of the agreement with Bosch, Hygreen will strategically deliver PEM projects over 1 MW size using Bosch’s Hybrion PEM stacks. The result is an expanded product portfolio with broader appeal to hydrogen project developers, EPCs, and industrial customers seeking flexibility, scalability, and speed to market, with two globally trusted brand names.
“We are proud to partner with Bosch, whose Hybrion PEM stack performance, high manufacturing standards, and scale capacity will help us serve a growing number of green hydrogen projects globally,” said Benny Wang, CEO of Hygreen Energy. “Through hundreds of successful deployments around the world, Hygreen has shown its capabilities already and we are looking forward to start a new and promising chapter with Bosch.”
Bosch’s Hybrion PEM stack delivers up to 1.25 MW of input power, up to 34 bar output pressure, and producing up to 23 kg of hydrogen per hour, while maintaining high efficiency and seamless integration into containerized and skid-mounted designs. Hygreen Energy will standardize this stack into its 1.25 MW and 5 MW hydrogen systems, enabling rapid deployment in projects ranging from energy storage to industrial decarbonization.
While Bosch brings manufacturing excellence, and high PEM stack quality standards, it is Hygreen’s system-level expertise that unlocks real-world performance. As a company that has delivered more than 300 hydrogen projects across five continents – from desert environments to polar research bases – Hygreen Energy’s in-market experience validates its ability to design, deliver, and support complete electrolyzer systems that project developers have come to trust.
“We are excited to bring large-scale hydrogen production systems to market with our partner Hygreen Energy.Scalability and manufacturing excellence are core to Bosch’s DNA and key to the future of a hydrogen economy. That’s how the Hybrion PEM electrolysis stack by Bosch contributes to a demand-oriented and clean hydrogen production with highest efficiency.” – Matthias Ziebell, Senior Vice President for Sales, Energy Markets, and Business Development, Robert Bosch GmbH.
About Hygreen Energy
Hygreen Energy is a world leading electrolyzer manufacturer that offers comprehensive solutions to green hydrogen production. Specializing in Alkaline, PEM, and AEM technologies, Hygreen electrolyzers are rigorously tested, robustly built, and extensively proven with in-field usage by customers worldwide. Backed by over 18 years of experience and over 300 electrolyzer projects delivered, Hygreen Energy’s engineers are some of the world’s most experienced professionals when supporting EPCs and hydrogen project developers. By transforming the electrolyzer industry with unparalleled efficiency, safety, cost, and durability, Hygreen Energy is enabling the world’s clean energy transition by supporting the growth of green hydrogen across many industries. Say hello to a greener future with Hygreen Energy, and visit us at www.hygreenenergy.com .
Trusted Coach Steps Into Leadership Role as Company Continues to Scale Internationally
SCOTTSDALE, ARIZONA / ACCESS Newswire / July 7, 2025 / Phone Ninjas, the automotive industry’s leader in dealership-specific coaching and training, proudly announces the promotion of Laura Taylor-Artl to Director of Account Services. Laura’s new role reflects her continued leadership in client operations, process execution, and team development across a rapidly expanding dealer portfolio.
LTA LTA Promoted
“Laura is the person you want talking with customers,” said Chris Vitale, COO at Phone Ninjas. “She’s detailed, dependable, and dealer-focused. As we scale, her leadership will ensure that every account receives the attention and strategy it deserves.”
Laura has been instrumental in building Phone Ninjas’ account service structure, helping onboard new clients, managing complex group rollouts, and ensuring coaching plans stay aligned with dealership goals. As Director, she will lead the account services team, standardize internal systems, and serve as a senior contact for high-level partners.
“What excites me is seeing dealership teams evolve,” said Laura. “When they decide to focus on the customer communications and start taking control of the conversation, you can feel the shift. It’s an impressive culture shift, and I love being a part of it.”
Laura’s promotion comes as Phone Ninjas continues its momentum across variable and fixed operations departments, helping clients improve communication performance where it matters most: at the frontline.
Founded in 2010, Phone Ninjas helps businesses master all client-facing communications with one goal in mind: better conversations that lead to better results. Through expertly designed ongoing coaching and training programs that support the sales, service, and parts departments, Phone Ninjas helps dealers turn all client interactions into appointments that show and buy.
STONY BROOK, NY / ACCESS Newswire / July 7, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that on July 2, 2025, it received written notice (the “Compliance Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires that companies listed on the Nasdaq Capital Market maintain a minimum bid price of $1.00 per share, and that the Company is therefore in compliance with the Nasdaq Capital Market’s listing requirements. Nasdaq also notified the Company in the Compliance Notice that the hearing before the Nasdaq Hearings Panel previously scheduled to take place on July 15, 2025, has been cancelled, and the Company’s securities will continue to be listed and traded on The Nasdaq Capital Market.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company with over 20 years of experience in developing and commercializing polymerase chain reaction (PCR)-based applications for DNA production. Through its majority-owned subsidiary, LineaRx Inc., the Company is commercializing its LineaDNA and LineaIVT platforms to enable the manufacture of next-generation nucleic acid-based therapies.
The statements made by Applied DNA Sciences in this press release may be “forward-looking” in nature within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe Applied DNA’s future plans, projections, strategies, and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. These forward-looking statements are based largely on the Company’s expectations and projections about future events and future trends affecting our business and are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. Actual results could differ materially from those projected due to the Company’s history of net losses, limited financial resources, substantial doubt regarding its ability to continue as a going concern, unknown future ability to continue its listing on the Nasdaq Capital Market, unknown future demand for its biotherapeutics products and services, the unknown amount of revenues and profits that will result from our LineaDNA and/or LineaIVT platforms, the fact that there has never been clinical trial material and/or a commercial drug product produced utilizing the LineaDNA and/or LineaIVT platforms, as well as various other factors detailed from time to time in Applied DNA’s SEC reports and filings, including its Annual Report on Form 10-K filed on December 17, 2024, its Quarterly Reports on Form 10-Q filed on February 13, 2025, and May 15, 2025, and other reports it files with the SEC, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date hereof or to reflect the occurrence of unanticipated events, unless otherwise required by law.
